A recent population-based study using diagnostic codes to compare the prevalence of CF-related conditions in more than 19,000 CFTR heterozygous mutant carriers and 99,000 healthy controls, found that CF carriers were at an increased risk for 59 CF-related diagnostic conditions [4]. This evidence concerns the gene CFTR and cystic fibrosis.